Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Quinlan Paul T. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. Cumulatively, 12 disclosures have been recorded. Activity tracked since 15 May 2023. The latest transaction was disclosed on 13 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
41,824 sharesCommon StockSEC:0000950170-24-035453:0
41,824 shares@ US$7.8971.3% of flowCommon StockSEC:0001062993-24-006510:0
28,438 shares0Common StockSEC:0001062993-24-001429:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-24-000923:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-022636:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-021137:0
5,000 shares@ US$2.943.3% of flowCommon StockSEC:0001062993-23-019547:0
5,000 shares@ US$2.9414.6% of flowCommon StockSEC:0001062993-23-018278:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-016606:0
5,000 shares@ US$2.943.1% of flowCommon StockSEC:0001062993-23-014924:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-014259:0
5,000 shares@ US$2.943.2% of flowCommon StockSEC:0001062993-23-011430:0